Serina Therapeutics Inc (SER): Next-Year EPS Estimate 31.52%
As of 2026-06-04, Serina Therapeutics Inc (SER) has a next-year EPS growth estimate of 31.52%.
On 2026-05-18, analyst consensus for SER's next-year EPS growth shifted from 25.53% to 31.52% — a positive change of 5.99 percentage points. The revised estimate has been sustained across 14 subsequent trading sessions. Current-year growth is projected at 3.66%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 31.52%
- EPS growth this year
- 3.66%
- EPS next quarter (est)
- -$0.46
- Last price
- $1.86
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 31.52% | 3.66% | -$0.46 | $1.86 |
| 2026-06-03 | 31.52% | 3.66% | -$0.46 | $1.79 |
| 2026-06-02 | 31.52% | 3.66% | -$0.46 | $1.76 |
| 2026-06-01 | 31.52% | 3.66% | -$0.46 | $1.81 |
| 2026-05-31 | 31.52% | 3.66% | -$0.46 | $1.84 |
| 2026-05-28 | 31.52% | 3.66% | -$0.46 | $1.95 |
| 2026-05-27 | 31.52% | 3.66% | -$0.46 | $1.80 |
| 2026-05-26 | 31.52% | 3.66% | -$0.46 | $1.92 |
| 2026-05-25 | 31.52% | 3.66% | -$0.46 | $1.98 |
| 2026-05-24 | 31.52% | 3.66% | -$0.46 | $1.98 |
| 2026-05-21 | 31.52% | 3.66% | -$0.46 | $1.89 |
| 2026-05-20 | 31.52% | 3.66% | -$0.46 | $1.70 |
| 2026-05-19 | 31.52% | 3.66% | -$0.46 | $1.61 |
| 2026-05-18 | 31.52% | 3.66% | -$0.46 | $1.51 |
| 2026-05-17 | 25.53% | 26.18% | -$0.35 | $1.64 |
| 2026-05-14 | 25.53% | 26.18% | -$0.44 | $1.72 |
| 2026-05-13 | 25.53% | 26.18% | -$0.44 | $1.54 |
| 2026-05-12 | 25.53% | 26.18% | -$0.44 | $1.63 |
| 2026-05-11 | 25.53% | 26.18% | -$0.44 | $1.60 |
| 2026-05-10 | 25.53% | 26.18% | -$0.44 | $1.75 |
| 2026-05-07 | 25.53% | 26.18% | -$0.44 | $1.81 |
| 2026-05-06 | 25.53% | 26.18% | -$0.44 | $1.83 |
| 2026-05-05 | 25.53% | 26.18% | -$0.44 | $1.80 |
| 2026-05-04 | 25.53% | 26.18% | -$0.44 | $1.90 |
| 2026-05-03 | 25.53% | 26.18% | -$0.44 | $1.82 |
| 2026-04-30 | 25.53% | 26.18% | -$0.44 | $1.82 |
| 2026-04-29 | 25.53% | 26.18% | -$0.44 | $1.83 |
| 2026-04-28 | 25.53% | 26.18% | -$0.44 | $1.85 |
| 2026-04-27 | 25.53% | 26.18% | -$0.44 | $1.80 |
| 2026-04-26 | 25.53% | 26.18% | -$0.44 | $1.97 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Serina Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Serina Therapeutics Inc (SER) has a next-year EPS growth estimate of 31.52%, based on analyst consensus.
When was the latest EPS estimate revision for SER?▾
The most recent revision occurred on 2026-05-18, when analysts adjusted the next-year EPS growth estimate from 25.53% to 31.52%.
What sector and industry does Serina Therapeutics Inc belong to?▾
Serina Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SER appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Serina Therapeutics Inc (SER) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports